Abstract
Adaptive stress responses mediated by the endocrine, autonomic, cardiovascular and immune systems are essential for the survival of the individual. Initial stress-induced responses provide a vital short-term metabolic lift, but prolonged or inappropriate exposure to stress can compromise homeostasis thereby leading to disease. This 'fight-or-flight' response is characterized by the activation of the corticotropin-releasing hormone (CRH)–adrenocorticotropin–glucocorticoid axis, mediated by the type 1 CRH receptor. In contrast, the type 2 CRH receptor mediates the stress-coping responses during the recovery phase of stress. We identified human stresscopin (SCP) and stresscopin-related peptide (SRP) as specific ligands for the type 2 CRH receptor. The genes encoding these peptides were expressed in diverse peripheral tissues as well as in the central nervous system. Treatment with SCP or SRP suppressed food intake, delayed gastric emptying and decreased heat-induced edema. Thus SCP and SRP might represent endogenous ligands for maintaining homeostasis after stress, and could allow the design of drugs to ameliorate stress-related diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Seyle, H. Stress and disease. Science 122, 625–631 (1955).
Spiess, J., Rivier, J., Rivier, C. & Vale, W. Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc. Natl. Acad. Sci. USA 78, 6517–6521 (1981).
Chen, R., Lewis, K.A., Perrin, M.H. & Vale, W.W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci. USA 90, 8967–8971 (1993).
Perrin, M.H. & Vale, W.W. Corticotropin releasing factor receptors and their ligand family. Ann. NY Acad. Sci. 885, 312–328 (1999).
Weninger, S.C. et al. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc. Natl. Acad. Sci. USA 96, 8283–8288 (1999).
Vaughan, J. et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378, 287–292 (1995).
Smith, G.W. et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20, 1093–1102 (1998).
Timpl, P. et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nature Genet. 19, 162–166 (1998).
Bale, T.L. et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nature Genet. 24, 410–414 (2000).
Kishimoto, T. et al. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nature Genet. 24, 415–419 (2000).
Coste, S.C. et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nature Genet. 24, 403–409 (2000).
Brar, B.K. et al. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J. Biol. Chem. 275, 8508–8514 (2000).
Bittencourt, J.C. et al. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J. Comp. Neurol. 415, 285–312 (1999).
Lau, S.H., Rivier, J., Vale, W., Kaiser, E.T. & Kezdy, F.J. Surface properties of an amphiphilic peptide hormone and of its analog: corticotropin-releasing factor and sauvagine. Proc. Natl. Acad. Sci. USA 80, 7070–7074 (1983).
Reyes, T.M. et al. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. USA 98, 2843–2848. (2001).
Brunner, B. et al. Molecular cloning and characterization of the Fugu rubripes MEST/COPG2 imprinting cluster and chromosomal localization in Fugu and Tetraodon nigroviridis. Chromosome Res. 8, 465–476 (2000).
Perrin, M. et al. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. USA 92, 2969–2973 (1995).
Lovenberg, T.W. et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA 92, 836–840 (1995).
Hauger, R.L., Dautzenberg, F.M., Flaccus, A., Liepold, T. & Spiess, J. Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: rapid and reversible homologous desensitization but prolonged recovery. J. Neurochem. 68, 2308–2316 (1997).
Kageyama, K., Gaudriault, G.E., Bradbury, M.J. & Vale, W.W. Regulation of corticotropin-releasing factor receptor type 2 beta messenger ribonucleic acid in the rat cardiovascular system by urocortin, glucocorticoids, and cytokines. Endocrinology 141, 2285–2293 (2000).
Turnbull, A.V., Vale, W. & Rivier, C. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. Eur. J. Pharmacol. 303, 213–216 (1996).
Heinrichs, S.C. & Richard, D. The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior. Neuropeptides 33, 350–359 (1999).
Nozu, T., Martinez, V., Rivier, J. & Tache, Y. Peripheral urocortin delays gastric emptying: role of CRF receptor 2. Am. J. Physiol. 276, G867–874 (1999).
Asakawa, A. et al. Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology 116, 1287–1292 (1999).
Chrousos, G.P. Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann. NY Acad. Sci. 851, 311–335 (1998).
Selye, H. The general adaptation syndrome and the diseases of adaptation. J. Clin. Endocrinol. 6, 117–230 (1946).
Hsu, S.Y. Cloning of two novel mammalian paralogs of relaxin/insulin family proteins and their expression in testis and kidney. Mol. Endocrinol. 13, 2163–2174. (1999).
Hsueh, A.J., Erickson, G.F. & Yen, S.S. Sensitisation of pituitary cells to luteinising hormone releasing hormone by clomiphene citrate in vitro. Nature 273, 57–59 (1978).
Hsu, S.Y., Liang, S.G. & Hsueh, A.J. Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region. Mol. Endocrinol. 12, 1830–1845 (1998).
Acknowledgements
We thank C. Klein, C. Spencer and A. Sanchez for technical and editorial assistance; and A. Payne and B. Kobilka for comments on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hsu, S., Hsueh, A. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7, 605–611 (2001). https://doi.org/10.1038/87936
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/87936
This article is cited by
-
Urocortin-3 neurons in the perifornical area are critical mediators of chronic stress on female infant-directed behavior
Molecular Psychiatry (2023)
-
Urocortin 3 overexpression reduces ER stress and heat shock response in 3T3-L1 adipocytes
Scientific Reports (2021)
-
Cancer-Specific Loss of Urocortin 3 in Human Renal Cancer
Advances in Therapy (2020)
-
Urocortins in the mammalian endocrine system
Acta Veterinaria Scandinavica (2019)
-
Urocortins and their unfolding role in mammalian social behavior
Cell and Tissue Research (2019)